Target intelligence / Profile preview

Neisseria meningitidis outer membrane vesicle PorA and associated surface proteins (PorA/OMV)

Target
PorA/OMV
Molecular classification
Bacterial outer membrane protein, Porin, Antigenic complex
01

Overview

PorA is a major class 1 outer membrane protein of Neisseria meningitidis that functions as a cation-selective porin, facilitating the transport of small hydrophilic molecules across the bacterial outer membrane (UniProt: P0A725). It is a highly immunogenic protein and serves as a primary target for the host's bactericidal antibody response during infection (PubMed: 22939900). Because PorA is highly variable among different strains, it is often delivered via outer membrane vesicles (OMVs), which are naturally occurring blebs of the bacterial membrane that preserve the protein's native conformation and include other surface antigens like PorB, RmpM, Opa, and Opc (PubMed: 15507154). These OMV-based formulations are critical components of vaccines designed to protect against Serogroup B meningococcal disease, for which traditional polysaccharide vaccines are ineffective due to the similarity between the Serogroup B capsule and human neural tissues (CDC: Meningococcal Vaccination). In clinical applications, such as the Bexsero vaccine, the OMV component provides specific protection against strains expressing matching PorA serosubtypes while also providing a synergistic effect with other recombinant antigens (EMA: Bexsero Summary of Product Characteristics). The primary mechanism of action involves the induction of serum bactericidal antibodies that trigger the complement system to lyse the bacteria. Monitoring efficacy typically involves measuring bactericidal titers against specific reference strains using the human serum bactericidal assay (hSBA).

Other names
Porin AClass 1 outer membrane proteinOMV-associated antigensMeningococcal outer membrane vesiclePorA/OMV complex
02

Mechanism of action

Induction of complement-mediated bactericidal antibody response

03

Biological functions

Ion transportMembrane permeabilityImmune response inductionBacterial adhesionPathogen-host interaction
04

Disease associations

Meningococcal meningitisMeningococcemiaInfection
05

Safety considerations

Injection site reactogenicityFeverStrain-specific coverage limitations due to PorA variability
06

Interacting drugs

Bexsero (4CMenB)

3 more in the full profile.

07

Biomarkers

Serum bactericidal activity (SBA) titershSBA (human Serum Bactericidal Assay) titers

Beyond the preview

Go deeper on Neisseria meningitidis outer membrane vesicle PorA and associated surface proteins (PorA/OMV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neisseria meningitidis outer membrane vesicle PorA and associated surface proteins (PorA/OMV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call